Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1995 1
1996 3
1997 3
1998 2
1999 2
2000 2
2001 4
2002 4
2003 6
2005 4
2006 7
2007 1
2008 3
2009 3
2010 7
2011 2
2012 2
2013 6
2014 5
2015 2
2016 2
2017 3
2018 3
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Online self-sampling kits for human immunodeficiency virus and other sexually transmitted infections: Feasibility, positivity rates, and factors associated with infections in France.
Rahib D, Bercot B, Delagreverie H, Gabassi A, Delaugerre C, Salord H, Icard V, Le Thi TT, Leveau B, Khiri H, Digne J, Didelot MN, Pisoni A, Tuaillon E, Lydié N, Vandentorren S. Rahib D, et al. Among authors: khiri h. Int J STD AIDS. 2022 Mar;33(4):355-362. doi: 10.1177/09564624211066447. Epub 2022 Feb 10. Int J STD AIDS. 2022. PMID: 35144493
Myasthenia gravis and hepatitis C virus infection.
Halfon P, Levy M, San Marco M, Gerolami V, Khiri H, Bourliere M, Feryn JM, Gastaut JL, Pouget J, Cartouzou G. Halfon P, et al. Among authors: khiri h. J Viral Hepat. 1996 Nov;3(6):329-32. doi: 10.1111/j.1365-2893.1996.tb00106.x. J Viral Hepat. 1996. PMID: 8947885
Hepatitis B virus genotypes and extrahepatic manifestations.
Cacoub P, Saadoun D, Bourlière M, Khiri H, Martineau A, Benhamou Y, Varastet M, Pol S, Thibault V, Rotily M, Halfon P. Cacoub P, et al. Among authors: khiri h. J Hepatol. 2005 Nov;43(5):764-70. doi: 10.1016/j.jhep.2005.05.029. Epub 2005 Jun 28. J Hepatol. 2005. PMID: 16087273 Clinical Trial.
Retreatment with direct-acting antivirals of genotypes 1-3-4 hepatitis C patients who failed an anti-NS5A regimen in real world.
Halfon P, Scholtès C, Izopet J, Larrat S, Trimoulet P, Zoulim F, Alric L, Métivier S, Leroy V, Ouzan D, de Lédinghen V, Mohamed S, Pénaranda G, Khiri H, Thélu MA, Plauzolles A, Chiche L, Bourlière M, Abravanel F. Halfon P, et al. Among authors: khiri h. J Hepatol. 2018 Mar;68(3):595-597. doi: 10.1016/j.jhep.2017.09.019. Epub 2017 Oct 4. J Hepatol. 2018. PMID: 28987520 No abstract available.
Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort.
Halfon P, Scholtès C, Izopet J, Larrat S, Trimoulet P, Zoulim F, Alric L, Métivier S, Leroy V, Ouzan D, de Lédinghen V, Mohamed S, Pénaranda G, Khiri H, Thélu MA, Plauzolles A, Chiche L, Bourlière M, Abravanel F. Halfon P, et al. Among authors: khiri h. Antivir Ther. 2018;23(4):307-314. doi: 10.3851/IMP3184. Antivir Ther. 2018. PMID: 28730994
76 results